Fate Therapeutics (FATE) PT Raised to $16 at Leerink Partners; 'IPSC Platform Key Value Driver'

March 6, 2018 5:27 AM

Leerink Partners raised its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found